Areas of Focus
- Medical Virology
- Molecular Mechanisms of Liver Diseases
Work Experience
- 2015-2021 Postdoctoral Researcher at National Institutes of Health, USA
- 2021-Present Distinguished Research Fellow at Wuhan University
Academic Background & Achievements
- 2003-2007 Bachelor in Biopharmaceuticals: Huazhong University of Science and Technology
- 2007-2009 Master in Biochemistry and Molecular Biology: Huazhong University of Science and Technology
- 2009-2015 PhD: Technical University of Munich
Publications
- Diminished hepatic IFN response following HCV clearance triggers HBV reactivation in coinfection, Xiaoming Cheng et al., 2020
- Hepatitis B virus evades innate immunity of hepatocytes but activates macrophages during infection, Xiaoming Cheng et al., 2017
- Key Milestones in HCV Discovery and Therapeutics, Xiaoming Cheng, Marc G. Ghany, 2020
- Clinical characteristics of COVID‐19 patients with hepatitis B virus infection—a retrospective study, Rui Liu et al., 2020
- PASylated interferon α efficiently suppresses hepatitis B virus and induces anti-HBs seroconversion in HBV-transgenic mice, Yuchen Xia et al., 2019
- Hepatitis B virus deregulates cell cycle to promote viral replication and a premalignant phenotype, Yuchen Xia et al., 2018
- Human stem cell-derived hepatocytes as a model for hepatitis B virus infection, spreading and virus-host interactions, Yuchen Xia et al., 2017
- Interferon-γ and Tumor Necrosis Factor-α Produced by T cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis, Yuchen Xia et al., 2016
- Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors, L. W. Meredith et al., 2016
- Specific and Nonhepatotoxic Degradation of Nuclear Hepatitis B Virus cccDNA, Julie Lucifora et al., 2014
Awards
- 2020 NIH Young Investigator Excellence
- 2015 NIH Visiting Scholar Fellowship
- 2014 European Association for the Study of the Liver Young Scientist Award